Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Tomoda

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Mode of action of microbial anti-MRSA agents]Hiroshi Tomoda
Chemical & Pharmaceutical Bulletin|February 3, 2016
New Approaches to Drug Discovery for Combating MRSAHiroshi Tomoda
Accounts of Chemical Research|September 7, 2007
Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agentsHiroshi Tomoda, Takayuki Doi
Pharmacology & Therapeutics|July 7, 2007
Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganismsHiroshi Tomoda, Satoshi Omura
Expert Opinion on Therapeutic Patents|June 1, 2010
Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor - WO2009126624Daisuke Matsuda, Hiroshi Tomoda
Current Opinion in Investigational Drugs (London, England : 2000)|October 2, 2007
DGAT inhibitors for obesityDaisuke Matsuda, Hiroshi Tomoda
Future Medicinal Chemistry|November 22, 2011
Isoform-specific inhibitors of ACATs: recent advances and promising developmentsTaichi Ohshiro, Hiroshi Tomoda
Expert Opinion on Therapeutic Patents|December 4, 2014
Acyltransferase inhibitors: a patent review (2010-present)Taichi Ohshiro, Hiroshi Tomoda
The Journal of Antibiotics|August 4, 2006
Biosynthesis of sespendoleRyuji Uchida, Hiroshi Tomoda, Satoshi Omura
Acta Pharmaceutica Sinica. B|December 30, 2015
Discovery of new hazimycin congeners from Kitasatospora sp. P07101Nobuhiro Koyama, Hirofumi Sato, Hiroshi Tomoda
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Mode of action of microbial anti-MRSA agents]Hiroshi Tomoda
Chemical & Pharmaceutical Bulletin|February 3, 2016
New Approaches to Drug Discovery for Combating MRSAHiroshi Tomoda
Accounts of Chemical Research|September 7, 2007
Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agentsHiroshi Tomoda, Takayuki Doi
Pharmacology & Therapeutics|July 7, 2007
Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganismsHiroshi Tomoda, Satoshi Omura
Expert Opinion on Therapeutic Patents|June 1, 2010
Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor - WO2009126624Daisuke Matsuda, Hiroshi Tomoda
Current Opinion in Investigational Drugs (London, England : 2000)|October 2, 2007
DGAT inhibitors for obesityDaisuke Matsuda, Hiroshi Tomoda
Future Medicinal Chemistry|November 22, 2011
Isoform-specific inhibitors of ACATs: recent advances and promising developmentsTaichi Ohshiro, Hiroshi Tomoda
Expert Opinion on Therapeutic Patents|December 4, 2014
Acyltransferase inhibitors: a patent review (2010-present)Taichi Ohshiro, Hiroshi Tomoda
The Journal of Antibiotics|August 4, 2006
Biosynthesis of sespendoleRyuji Uchida, Hiroshi Tomoda, Satoshi Omura
Acta Pharmaceutica Sinica. B|December 30, 2015
Discovery of new hazimycin congeners from Kitasatospora sp. P07101Nobuhiro Koyama, Hirofumi Sato, Hiroshi Tomoda
Pageof 24